RxDoctor Payments Data

Mazyar Motahedeh

Los Angeles, CANPI 1619250172

Payments from drug & device makers

$6,115in general payments, 2019–2025

Across 253 payments — averaging $24.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Antares Pharma, Inc.$663
  • Myriad Genetic Laboratories, Inc.$609
  • Johnson & Johnson$528
  • Pfizer$442
  • Progenics Pharmaceuticals, Inc.$370
  • plus $2K from 33 others

What the payments were for

  • Food & beverage$5,93097%
  • Education$1853%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Where these figures come from

Is this you, or does something look wrong? →